Oil prices rise after EU agrees Russian sanctions
Edward Jay Kreps, CEO of Confluent , Inc. (NASDAQ:CFLT), a $8.3 billion market cap company showing strong revenue growth of 24%, recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Kreps sold a total of 232,500 shares of Class A Common Stock on June 5, 2025. The sales were executed at prices ranging from $24.43 to $24.98 per share, amounting to a total transaction value of approximately $5.7 million.
The transactions were conducted under a 10b5-1 trading plan, which Kreps adopted on August 15, 2024. Following these sales, Kreps holds 452,488 shares directly. Additionally, Kreps converted 232,500 shares of Class B Common Stock to Class A Common Stock, although these conversions were not part of the sale transactions.
This sale is part of Kreps’ ongoing management of his equity in Confluent, a company known for its data streaming platform. While currently unprofitable, InvestingPro analysis shows the company maintains strong liquidity with more cash than debt, and analysts expect profitability this year. Investors will be watching closely to see how these transactions might impact Confluent’s stock performance in the coming months, with analyst price targets ranging from $22 to $39.78 per share.
In other recent news, Confluent Inc reported its first-quarter 2025 earnings, which saw subscription revenue reach $260.9 million, marking a 26% year-over-year increase. Despite this strong performance, Confluent has revised its full-year guidance, citing uncertainties in market conditions. The company anticipates a cautious revenue outlook for 2025, with projections for subscription revenue now set at $1,100-1,110 million. This adjustment reflects concerns over large customer engagements and macroeconomic factors, as noted by analysts from Citi and Needham.
Additionally, several analysts have revised their price targets for Confluent. Citi lowered its target to $25, maintaining a Neutral rating, while Canaccord Genuity reduced its target to $32 but kept a Buy rating. Needham also cut its target to $26, reaffirming a Buy rating, and Bernstein adjusted its target to $32, maintaining an Outperform rating. Evercore ISI slightly reduced its target to $28, continuing to rate the stock as Outperform. These adjustments highlight the mixed sentiment among analysts regarding Confluent’s future growth prospects amid current market challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.